Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-31 Purchase | 2025-04-02 3:46 pm | Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director | 35,640 | $0.56 | $19,958 | 35,640 (Direct) | View |
| 2025-03-21 Purchase | 2025-03-25 6:46 pm | Lyell Immunopharma Inc. | LYEL | Ramachandra Sumant Director | 200,000 | $0.5761 | $115,220 | 200,000 (Indirect) | View |
| 2025-03-14 Purchase | 2025-03-18 8:07 pm | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 158,000 | $0.6009 | $94,942 | 3,811,199 (Indirect Direct) | View |
| 2025-03-17 Purchase | 2025-03-18 7:01 pm | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 200,000 | $0.5581 | $111,620 | 372,725 (Indirect Direct) | View |
| 2025-03-14 Purchase | 2025-03-18 6:59 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 175,000 | $0.6068 | $106,190 | 712,500 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 4:23 pm | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 58,020 | $2.28 | $132,286 | 3,898,714 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-10 Option Award | 2025-02-26 7:36 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Lang Matthew Chief Business Officer | 618,750 | $0 | 668,750 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:33 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 1,856,250 | $0 | 2,056,250 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:31 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 618,750 | $0 | 679,149 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:29 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 618,750 | $0 | 678,975 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-26 7:27 pm | N/A 2035-02-09 | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 618,750 | $0 | 682,946 (Direct) | View |
| 2024-10-31 Option Award | 2024-11-01 4:56 pm | N/A 2034-10-30 | Lyell Immunopharma Inc. | LYEL | Ramachandra Sumant Director | 260,000 | $0 | 260,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:41 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 130,000 | $0 | 36,542,716 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:17 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director | 130,000 | $0 | 4,815,614 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:15 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 130,000 | $0 | 3,783,199 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:13 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director | 130,000 | $0 | 130,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:09 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | NABEL ELIZABETH G Director | 130,000 | $0 | 130,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:07 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director | 130,000 | $0 | 130,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:05 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director | 130,000 | $0 | 466,370 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 8:25 pm | N/A 2034-02-08 | Lyell Immunopharma Inc. | LYEL | Lang Matthew Chief Business Officer | 550,000 | $0 | 550,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 8:24 pm | N/A 2034-02-08 | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 440,000 | $0 | 448,928 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 8:22 pm | N/A 2034-02-08 | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 440,000 | $0 | 452,700 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 8:19 pm | N/A 2034-02-08 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 440,000 | $0 | 448,729 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 8:17 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-11-16 Disposition | 2023-11-20 8:55 pm | N/A 2031-02-04 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 4,818,000 | $0 | 4,826,729 (Direct) | View |
| 2023-11-16 Option Award | 2023-11-20 8:55 pm | N/A 2031-02-04 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 4,818,000 | $0 | 4,826,729 (Direct) | View |
| 2023-11-16 Disposition | 2023-11-20 8:54 pm | N/A 2032-02-10 | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 800,000 | $0 | 812,700 (Direct) | View |
| 2023-11-16 Option Award | 2023-11-20 8:54 pm | N/A 2032-02-10 | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 800,000 | $0 | 812,700 (Direct) | View |
| 2023-11-16 Disposition | 2023-11-20 8:53 pm | N/A 2032-12-14 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 7,500,000 | $0 | 7,500,000 (Direct) | View |
| 2023-11-16 Option Award | 2023-11-20 8:53 pm | N/A 2032-12-14 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 7,500,000 | $0 | 7,500,000 (Direct) | View |
| 2023-11-16 Disposition | 2023-11-20 8:52 pm | N/A 2029-11-30 | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Technical Ops. Officer | 2,000,000 | $0 | 2,008,928 (Direct) | View |
| 2023-11-16 Option Award | 2023-11-20 8:52 pm | N/A 2029-11-30 | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Technical Ops. Officer | 2,000,000 | $0 | 2,008,928 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-08 4:30 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 55,000 | $0 | 3,953,714 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-08 4:27 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-08 4:26 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director | 55,000 | $0 | 391,370 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-08 4:24 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 55,000 | $0 | 36,467,716 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-08 4:23 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | NABEL ELIZABETH G Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-08 4:22 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-08 4:20 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director | 55,000 | $0 | 4,740,614 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-11 4:24 pm | N/A 2033-08-09 | Lyell Immunopharma Inc. | LYEL | Lang Matthew Chief Business Officer | 2,250,000 | $0 | 2,250,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 4:51 pm | N/A 2033-06-15 | Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 4:49 pm | N/A 2033-06-15 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 36,477,716 (Direct) | View |